表紙
市場調查報告書

乾眼症症候群治療的全球市場:產業趨勢·預測

Global Dry Eye Syndrome Treatment Market: Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 904381
出版日期 內容資訊 英文 217 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
乾眼症症候群治療的全球市場:產業趨勢·預測 Global Dry Eye Syndrome Treatment Market: Industry Trends and Forecast to 2026
出版日期: 2019年07月01日內容資訊: 英文 217 Pages
簡介

本報告提供全球乾眼症症候群治療市場相關調查分析,提供市場概要,市場趨勢,各市場區隔的市場分析,各地區預測,主要企業等相關的系統性資訊。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球乾眼症症候群治療市場:各產品類型

  • 概要
  • 乳劑
  • 潤滑劑滴眼液/眼科用液劑
  • 眼用軟膏
  • 營養補充品
  • 自我血清眼科用藥
  • 其他

第7章 全球乾眼症症候群治療市場:各疾病類型

  • 概要
  • 汽化亢進型乾眼症
  • 淚液減少型乾眼症

第8章 全球乾眼症症候群治療市場:各治療類型

  • 概要
  • 眼淚刺激劑
  • 潤滑點眼藥劑
  • 抗發炎藥
  • 人工淚液
  • 抗生素

第9章 全球乾眼症症候群治療市場:各終端用戶

  • 概要
  • 居家醫療
  • 醫院
  • 診所
  • 其他

第10章 全球乾眼症症候群治療市場:各銷售管道

  • 概要
  • 零售藥局
  • 醫院藥局
  • 線上藥局
  • 其他

第11章 全球乾眼症症候群治療市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第12章 全球乾眼症症候群治療市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第13章 企業簡介

  • ALLERGAN
  • ALCON INC
  • BAUSCH & LOMB INCORPORATED
  • NOVARTIS AG
  • JOHNSON & JOHNSON SERVICES, INC.
  • AKORN, INCORPORATED
  • HORUS PHARMA
  • MITOTECH, SA
  • NOVALIQ GMBH
  • PRESTIGE CONSUMER HEALTHCARE, INC.
  • 參天製藥
  • 千壽製藥
  • SIMILASAN
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • VISUFARMA

第14章 詢問調查

第15章 相關調查

目錄

Global dry eye syndrome treatment market is projected to register a substantial CAGR of 6.8% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product Type (Emulsions, Lubricant Eye Drops/Solutions, Eye Ointments, Autologous Serum Eye Drops, Nutrition Supplements, Others), Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Treatment Type (Lubricating Agents, Tear Stimulators, Artificial Tears, Anti-Inflammatory Drugs, Antibiotic Drugs, Others), End User (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Some of the major factors contributing to the growth of the global dry eye syndrome treatment market:

  • Owing to the increasing number of eye diseases there is a wide acceptance of dry eye syndrome treatment
  • Growing government funding and initiatives for the development of new drugs for eye treatment

Market Players:

The key market players for global dry eye syndrome treatment market are listed below:

  • Mitotech, SA
  • Johnson & Johnson Services, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • ALLERGAN
  • Novaliq GmbH
  • Prestige Consumer Healthcare, Inc.
  • Horus Pharma
  • Senju Pharmaceutical Co. Ltd.
  • VISUfarma
  • Akorn, Incorporated
  • Bausch & Lomb Incorporated
  • Teva Pharmaceutical Industries Ltd.
  • Alcon Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Novartis AG
  • Similasan
  • Others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL DRY EYE SYNDROME TREATMENT MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING PREVALENCE OF DRY EYE DISEASES
    • 3.1.2 CHANGING GEOGRAPHICAL TRENDS TO DRIVE THE MARKET
    • 3.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
    • 3.1.4 RISING GERIATRIC POPULATION ACROSS THE WORLD
    • 3.1.5 INCREASE IN LASIK SURGERY AND USAGE OF CONTACT LENSES
  • 3.2 RESTRAINTS
    • 3.2.1 STRINGENT REGULATORY PROCESS
    • 3.2.2 UNMET MEDICAL NEEDS
  • 3.3 OPPORTUNITIES
    • 3.3.1 EMERGING MARKET PRESENTS SIGNIFICANT OPPORTUNITIES
    • 3.3.2 DEVELOPMENT OF NOVEL TECHNOLOGIES
  • 3.4 CHALLENGE
    • 3.4.1 INCREASING NUMBER OF PLAYERS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 EMULSIONS
  • 6.3 LUBRICANT EYE DROPS/SOLUTIONS
    • 6.3.1 OILY TEAR EYE DROP
    • 6.3.2 PRESERVATIVE-FREE DROPS
  • 6.4 EYE OINTMENTS
  • 6.5 NUTRITION SUPPLEMENTS
  • 6.6 AUTOLOGOUS SERUM EYE DROPS
  • 6.7 OTHERS

7 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE

  • 7.1 OVERVIEW
  • 7.2 EVAPORATIVE DRY EYE SYNDROME
  • 7.3 AQUEOUS DRY EYE SYNDROME

8 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE

  • 8.1 OVERVIEW
  • 8.2 TEAR STIMULATORS
  • 8.3 LUBRICATING AGENTS
  • 8.4 ANTI-INFLAMMATORY DRUGS
  • 8.5 ARTIFICIAL TEARS
  • 8.6 ANTIBIOTIC DRUGS
  • 8.7 OTHERS

9 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 HOME HEALTHCARE
  • 9.3 HOSPITALS
  • 9.4 CLINICS
  • 9.5 OTHERS

10 GLOBAL DRY EYE SYNDROME TREATMENTMARKET, BY DISTRIBUTION CHANNEL

  • 10.1 OVERVIEW
  • 10.2 RETAIL PHARMACIES
  • 10.3 HOSPITAL PHARMACIES
  • 10.4 ONLINE PHARMACIES
  • 10.5 OTHERS

11 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY GEOGRAPHY

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 U.K.
    • 11.3.3 FRANCE
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 RUSSIA
    • 11.3.7 NETHERLANDS
    • 11.3.8 SWITZERLAND
    • 11.3.9 BELGIUM
    • 11.3.10 TURKEY
    • 11.3.11 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 JAPAN
    • 11.4.2 CHINA
    • 11.4.3 SOUTH KOREA
    • 11.4.4 INDIA
    • 11.4.5 AUSTRALIA
    • 11.4.6 SINGAPORE
    • 11.4.7 THAILAND
    • 11.4.8 MALAYSIA
    • 11.4.9 INDONESIA
    • 11.4.10 PHILIPPINES
    • 11.4.11 REST OF ASIA PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 SOUTH AFRICA
    • 11.6.2 REST OF MIDDLE EAST AND AFRICA

12 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, COMPANY LANDSCAPE

  • 12.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 12.3 COMPANY SHARE ANALYSIS: EUROPE
  • 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 COMPANY PROFILES

  • 13.1 ALLERGAN
    • 13.1.1 COMPANY SNAPSHOT
    • 13.1.2 COMPANY SHARE ANALYSIS
    • 13.1.3 REVENUE ANALYSIS
    • 13.1.4 GEOGRAPHICAL PRESENCE
    • 13.1.5 PRODUCT PORTFOLIO
    • 13.1.6 RECENT DEVELOPMENTS
  • 13.2 ALCON INC
    • 13.2.1 COMPANY SNAPSHOT
    • 13.2.2 COMPANY SHARE ANALYSIS
    • 13.2.3 REVENUE ANALYSIS
    • 13.2.4 GEOGRAPHICAL PRESENCE
    • 13.2.5 PRODUCT PORTFOLIO
  • 13.3 BAUSCH & LOMB INCORPORATED.
    • 13.3.1 COMPANY SNAPSHOT
    • 13.3.2 COMPANY SHARE ANALYSIS
    • 13.3.3 REVENUE ANALYSIS
    • 13.3.4 GEOGRAPHICAL PRESENCE
    • 13.3.5 PRODUCT PORTFOLIO
    • 13.3.6 RECENT DEVELOPMENT
  • 13.4 NOVARTIS AG
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 COMPANY SHARE ANALYSIS
    • 13.4.3 REVENUE ANALYSIS
    • 13.4.4 GEOGRAPHICAL PRESENCE
    • 13.4.5 PRODUCT PORTFOLIO
    • 13.4.6 RECENT DEVELOPMENT
  • 13.5 JOHNSON & JOHNSON SERVICES, INC.
    • 13.5.1 COMPANY SNAPSHOT
    • 13.5.2 COMPANY SHARE ANALYSIS
    • 13.5.3 REVENUE ANALYSIS
    • 13.5.4 GEOGRAPHICAL PRESENCE
    • 13.5.5 PRODUCT PORTFOLIO
    • 13.5.6 RECENT DEVELOPMENTS
  • 13.6 AKORN, INCORPORATED
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 REVENUE ANALYSIS
    • 13.6.3 GEOGRAPHICAL PRESENCE
    • 13.6.4 PRODUCT PORTFOLIO
    • 13.6.5 RECENT DEVELOPMENT
  • 13.7 HORUS PHARMA
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 GEOGRAPHICAL PRESENCE
    • 13.7.3 PRODUCT PORTFOLIO
    • 13.7.4 RECENT DEVELOPMENT
  • 13.8 MITOTECH, SA
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 GEOGRAPHICAL PRESENCE
    • 13.8.3 PORTFOLIO
    • 13.8.4 RECENT DEVELOPMENTS
  • 13.9 NOVALIQ GMBH
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 GEOGRAPHICAL PRESENCE
    • 13.9.3 PRODUCT PORTFOLIO
    • 13.9.4 RECENT DEVELOPMENT
  • 13.10 PRESTIGE CONSUMER HEALTHCARE, INC.
    • 13.10.1 COMPANY SNAPSHOT
    • 13.10.2 REVENUE ANALYSIS
    • 13.10.3 GEOGRAPHICAL PRESENCE
    • 13.10.4 PRODUCT PORTFOLIO
    • 13.10.5 RECENT DEVELOPMENT
  • 13.11 SANTEN PHARMACEUTICAL CO., LTD.
    • 13.11.1 COMPANY OVERVIEW
    • 13.11.2 REVENUE ANALYSIS
    • 13.11.3 GEOGRAPHICAL PRESENCE
    • 13.11.4 PRODUCT PORTFOLIO
    • 13.11.5 RECENT DEVELOPMENT
  • 13.12 SENJU PHARMACEUTICAL CO. LTD.
    • 13.12.1 COMPANY OVERVIEW
    • 13.12.2 REVENUE ANALYSIS
    • 13.12.3 GEOGRAPHICAL PRESENCE
    • 13.12.4 PRODUCT PORTFOLIO
    • 13.12.5 RECENT DEVELOPMENT
  • 13.13 SIMILASAN
    • 13.13.1 COMPANY OVERVIEW
    • 13.13.2 GEOGRAPHICAL PRESENCE
    • 13.13.3 PRODUCT PORTFOLIO
    • 13.13.4 RECENT DEVELOPMENT
  • 13.14 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 13.14.1 COMPANY SNAPSHOT
    • 13.14.2 REVENUE ANALYSIS
    • 13.14.3 GEOGRAPHICAL PRESENCE
    • 13.14.4 PRODUCT PORTFOLIO
    • 13.14.5 RECENT DEVELOPMENTS
  • 13.15 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 13.15.1 COMPANY SNAPSHOT
    • 13.15.2 REVENUE ANALYSIS
    • 13.15.3 GEOGRAPHICAL PRESENCE
    • 13.15.4 PRODUCT PORTFOLIO
    • 13.15.5 RECENT DEVELOPMENT
  • 13.16 VISUFARMA
    • 13.16.1 COMPANY OVERVIEW
    • 13.16.2 GEOGRAPHICAL PRESENCE
    • 13.16.3 PRODUCT PORTFOLIO
    • 13.16.4 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION
  • TABLE 2 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 3 GLOBAL EMULSIONS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 4 GLOBAL LUBRICANT EYE DROPS/SOLUTIONS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 5 GLOBAL LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 6 GLOBAL EYE OINTMENTS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 GLOBAL NUTRITION SUPPLEMENTS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 GLOBAL AUTOLOGOUS SERUM EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 GLOBAL OTHERS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 11 GLOBAL EVAPORATIVE DRY EYE SYNDROME IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 GLOBAL AQUEOUS DRY EYE SYNDROME IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 14 GLOBAL TEAR STIMULATORS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 GLOBAL LUBRICATING AGENTS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 GLOBAL ANTI-INFLAMMATORY DRUGS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 GLOBAL ARTIFICIAL TEARS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 GLOBAL ANTIBIOTIC DRUGS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 GLOBAL OTHERS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 21 GLOBAL HOME HEALTHCARE IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22 GLOBAL HOSPITALS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 GLOBAL CLINICS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24 GLOBAL OTHERS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 26 GLOBAL RETAIL PHARMACIES IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 27 GLOBAL HOSPITAL PHARMACIES IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 GLOBAL ONLINE PHARMACIES IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 GLOBAL OTHERS IN DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 32 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 33 NORTH AMERICA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 34 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 35 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 36 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 37 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 38 U.S. DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 39 U.S. LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 40 U.S. DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 41 U.S. DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 42 U.S. DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 43 U.S. DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 44 CANADA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 45 CANADA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 CANADA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 47 CANADA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 48 CANADA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 49 CANADA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 50 MEXICO DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 51 MEXICO LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 52 MEXICO DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 53 MEXICO DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 54 MEXICO DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 55 MEXICO DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 56 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 57 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 58 EUROPE LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 59 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 60 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 61 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 62 EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 63 GERMANY DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 64 GERMANY LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 65 GERMANY DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 66 GERMANY DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 67 GERMANY DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 68 GERMANY DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 69 U.K. DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 70 U.K. LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 71 U.K. DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 72 U.K. DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 73 U.K. DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 74 U.K. DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 75 FRANCE DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 76 FRANCE LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 77 FRANCE DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 78 FRANCE DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 79 FRANCE DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 80 FRANCE DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 81 ITALY DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 82 ITALY LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 83 ITALY DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 84 ITALY DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 85 ITALY DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 86 ITALY DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 87 SPAIN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 88 SPAIN LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 89 SPAIN DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 90 SPAIN DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 91 SPAIN DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 92 SPAIN DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 93 RUSSIA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 94 RUSSIA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 95 RUSSIA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 96 RUSSIA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 97 RUSSIA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 98 RUSSIA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 99 NETHERLANDS DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 100 NETHERLANDS LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 101 NETHERLANDS DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 102 NETHERLANDS DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 103 NETHERLANDS DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 104 NETHERLANDS DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 105 SWITZERLAND DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 106 SWITZERLAND LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 107 SWITZERLAND DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 108 SWITZERLAND DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 109 SWITZERLAND DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 110 SWITZERLAND DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 111 BELGIUM DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 112 BELGIUM LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 113 BELGIUM DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 114 BELGIUM DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 115 BELGIUM DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 116 BELGIUM DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 117 TURKEY DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 118 TURKEY LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 119 TURKEY DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 120 TURKEY DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 121 TURKEY DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 122 TURKEY DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 123 REST OF EUROPE DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 124 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET,BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 125 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 126 ASIA-PACIFIC LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 127 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 128 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 129 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 130 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 131 JAPAN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 132 JAPAN LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 133 JAPAN DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 134 JAPAN DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 135 JAPAN DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 136 JAPAN DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 137 CHINA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2016-2026 2017-2026 (USD MILLION)
  • TABLE 138 CHINA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 139 CHINA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION))
  • TABLE 140 CHINA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 141 CHINA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 142 CHINA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 143 SOUTH KOREA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 144 SOUTH KOREA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 145 SOUTH KOREA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 146 SOUTH KOREA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 147 SOUTH KOREA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 148 SOUTH KOREA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 149 INDIA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 150 INDIA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 151 INDIA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 152 INDIA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 153 INDIA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 154 INDIA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 155 AUSTRALIA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 156 AUSTRALIA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 157 AUSTRALIA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 158 AUSTRALIA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 159 AUSTRALIA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 160 AUSTRALIA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 161 SINGAPORE DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 162 SINGAPORE LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 163 SINGAPORE DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 164 SINGAPORE DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 165 SINGAPORE DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 166 SINGAPORE DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 167 THAILAND DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 168 THAILAND LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 169 THAILAND DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 170 THAILAND DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 171 THAILAND DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 172 THAILAND DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 173 MALAYSIA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 174 MALAYSIA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 175 MALAYSIA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 176 MALAYSIA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 177 MALAYSIA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 178 MALAYSIA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 179 INDONESIA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 180 INDONESIA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 181 INDONESIA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 182 INDONESIA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 183 INDONESIA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 184 INDONESIA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 185 PHILIPPINES DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 186 PHILIPPINES LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 187 PHILIPPINES DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 188 PHILIPPINES DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 189 PHILIPPINES DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 190 PHILIPPINES DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 192 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 193 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 194 SOUTH AMERICA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 195 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 196 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 197 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 198 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 199 BRAZIL DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 200 BRAZIL LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 201 BRAZIL DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 202 BRAZIL DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 203 BRAZIL DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 204 BRAZIL DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 205 REST OF SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 206 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 207 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 208 MIDDLE EAST AND AFRICA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 209 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 210 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 211 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 212 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 213 SOUTH AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 214 SOUTH AFRICA LUBRICANT EYE DROPS IN DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 215 SOUTH AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
  • TABLE 216 SOUTH AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 217 SOUTH AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 218 SOUTH AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 219 REST OF MIDDLE EAST & AFRICA DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: DATA VALIDATION MODEL
  • FIGURE 3 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: GLOBAL VS REGIONAL
  • FIGURE 5 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF GLOBAL DRY EYE SYNDROME TREATMENT MARKET
  • FIGURE 10 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: SEGMENTATION
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE DRY EYE SYNDROME TREATMENT MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026
  • FIGURE 12 INCREASING PREVALENCE OF DRY EYE DISEASES AND CHANGING GEOGRAPHICAL TRENDS TO DRIVE THE MARKET ARE EXPECTED TO DRIVE THE GLOBAL DRY EYE SYNDROME TREATMENT MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 13 EMULSIONS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DRY EYE SYNDROME TREATMENT MARKET IN 2019 & 2026
  • FIGURE 14 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL DRY EYE SYNDROME TREATMENT MARKET IN THE FORECAST PERIOD FROM 2019 TO 2026
  • FIGURE 15 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE, 2018
  • FIGURE 16 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY DISEASE TYPE, 2018
  • FIGURE 17 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY TREATMENT TYPE, 2018
  • FIGURE 18 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY END USER, 2018
  • FIGURE 19 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 20 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: SNAPSHOT (2018)
  • FIGURE 21 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY GEOGRAPHY (2018)
  • FIGURE 22 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY GEOGRAPHY (2019 & 2026)
  • FIGURE 23 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY GEOGRAPHY (2018 & 2026)
  • FIGURE 24 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 25 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: SNAPSHOT (2018)
  • FIGURE 26 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018)
  • FIGURE 27 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 28 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 29 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 30 EUROPE DRY EYE SYNDROME TREATMENT: SNAPSHOT (2018)
  • FIGURE 31 EUROPE DRY EYE SYNDROME TREATMENT: BY COUNTRY (2018)
  • FIGURE 32 EUROPE DRY EYE SYNDROME TREATMENT: BY COUNTRY (2019 & 2026)
  • FIGURE 33 EUROPE DRY EYE SYNDROME TREATMENT: BY COUNTRY (2018 & 2026)
  • FIGURE 34 EUROPE DRY EYE SYNDROME TREATMENT: BY PRODUCT TYPE (2019-2026)
  • FIGURE 35 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT: SNAPSHOT (2018)
  • FIGURE 36 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT: BY COUNTRY (2018)
  • FIGURE 37 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT: BY COUNTRY (2019 & 2026)
  • FIGURE 38 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT: BY COUNTRY (2018 & 2026)
  • FIGURE 39 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT: BY PRODUCT TYPE (2019-2026)
  • FIGURE 40 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: SNAPSHOT (2018)
  • FIGURE 41 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018)
  • FIGURE 42 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 43 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 44 SOUTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: BY PRODUCTS TYPE (2019-2026)
  • FIGURE 45 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET: SNAPSHOT (2018)
  • FIGURE 46 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018)
  • FIGURE 47 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 48 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 49 MIDDLE EAST AND AFRICA DRY EYE SYNDROME TREATMENT MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 50 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: COMPANY SHARE 2018
  • FIGURE 51 NORTH AMERICA DRY EYE SYNDROME TREATMENT MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 52 EUROPE DRY EYE SYNDROME TREATMENT MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 53 ASIA-PACIFIC DRY EYE SYNDROME TREATMENT MARKET: COMPANY SHARE 2018 (%)
Back to Top